1801HK: Innovent licensed in KRAS G12C drug obtained NMPA BTD designation(/);1810 HK: Oppo abruptly abandons development of self-developed chips (-); 3690.HK: A review of Meituan’s in-store strategy
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.